Seeking men and women with myelofibrosis bone marrow cancer for a study of an investigational drug given alone or in combination with a standard treatment.
Based on their current treatment and illness, participants in this study will get the standard drug in combination with either a high or low dose of the investigational drug, or a high dose of the investigational drug alone.
What we're hoping for
We are studying whether an investigational drug given alone or in combination with a standard drug for myelofibrosis bone marrow cancer is safe and effective in preventing the disease from progressing.
ClinicalTrials.gov Identifier: NCT03222609